Los Angeles Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,359
| Closed | -$61.3K | – | 1255 |
|
|
2024
Q1 | $61.3K | Hold |
16,359
| – | – | ﹤0.01% | 1121 |
|
|
2023
Q4 | $160K | Hold |
16,359
| – | – | ﹤0.01% | 1109 |
|
|
2023
Q3 | $137K | Buy |
16,359
+812
| +5% | +$6.78K | ﹤0.01% | 1081 |
|
|
2023
Q2 | $207K | Buy |
+15,547
| New | +$207K | ﹤0.01% | 1113 |
|
|
2022
Q4 | – | Sell |
-27,526
| Closed | -$160K | – | 1255 |
|
|
2022
Q3 | $160K | Buy |
27,526
+55
| +0.2% | +$320 | ﹤0.01% | 1186 |
|
|
2022
Q2 | $121K | Buy |
27,471
+5,410
| +25% | +$23.8K | ﹤0.01% | 1284 |
|
|
2022
Q1 | $201K | Hold |
22,061
| – | – | ﹤0.01% | 1360 |
|
|
2021
Q4 | $451K | Sell |
22,061
-614
| -3% | -$12.6K | ﹤0.01% | 1057 |
|
|
2021
Q3 | $579K | Hold |
22,675
| – | – | ﹤0.01% | 984 |
|
|
2021
Q2 | $793K | Sell |
22,675
-4,560
| -17% | -$159K | ﹤0.01% | 954 |
|
|
2021
Q1 | $907K | Sell |
27,235
-14,875
| -35% | -$495K | ﹤0.01% | 939 |
|
|
2020
Q4 | $1.09M | Sell |
42,110
-175,170
| -81% | -$4.54M | ﹤0.01% | 904 |
|
|
2020
Q3 | $2.15M | Sell |
217,280
-23,579
| -10% | -$233K | 0.01% | 546 |
|
|
2020
Q2 | $831K | Buy |
+240,859
| New | +$831K | ﹤0.01% | 918 |
|
|
2014
Q2 | – | Sell |
-72,060
| Closed | -$386K | – | 1268 |
|
|
2014
Q1 | $386K | Buy |
+72,060
| New | +$386K | ﹤0.01% | 973 |
|